13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000884300
Total reported value
$127.2M
$127.2M
90 檔
26.2%
According to the latest 13F quarterly dataset, Perkins Capital Management Inc managed an equity portfolio of $127.2M at the end of Q1 2024, spanning 90 distinct U.S. exchange-listed positions.
During Q1 2024, Perkins Capital Management Inc's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 8.20% | +0.58% | -1.02% | |
| 2 | MSFT | Microsoft CORP | Stock-Tech | 5.31% | -0.68% | -1.30% | |
| 3 | AUGX | Augmedix Inc | Stock-Other | 4.97% | — | -0.43% | |
| 4 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 4.73% | -1.09% | — | |
| 5 | NTRA | Natera Inc | Stock-Healthcare | 4.59% | +0.37% | -2.83% | |
| 6 | AMD | Advanced Micro Devices | Stock-Tech | 3.39% | +3.39% | -2.38% | |
| 7 | QUIK | Quicklogic CORP | Stock-Other | 2.76% | +1.35% | -7.19% | |
| 8 | NEO | Neogenomics Inc | Stock-Healthcare | 2.53% | +0.34% | — | |
| 9 | ABT | Abbott Laboratories | Stock-Healthcare | 2.41% | -0.54% | — | |
| 10 | VCYT | Veracyte Inc | Stock-Other | 2.14% | +0.50% | -1.02% | |
| 11 | ATEC | Alphatec Holdings Inc | Stock-Other | 2.12% | -0.56% | -0.32% | |
| 12 | ELUT | Elutia Inc | Stock-Other | 2.09% | -0.44% | +2.45% | |
| 13 | AXGN | Axogen Inc | Stock-Other | 2.00% | +0.13% | -0.56% | |
| 14 | INUVGBP | Inuvo Inc | Stock-Other | 2.00% | — | -0.28% | |
| 15 | LMAT | Lemaitre Vascular Inc | Stock-Other | 1.95% | -0.73% | — | |
| 16 | DGII | Digi International Inc | Stock-Other | 1.91% | -0.33% | EXIT | |
| 17 | AIRG | Airgain Inc | Stock-Other | 1.71% | — | -1.23% | |
| 18 | USIO | Usio Inc | Stock-Other | 1.48% | +0.62% | +0.19% | |
| 19 | PFIEEUR | Profire Energy Inc | Stock-Other | 1.46% | — | +0.94% | |
| 20 | UTE0 | Cantaloupe Inc | Stock-Other | 1.37% | — | -1.92% | |
| 21 | FPAYQ | Flexshopper Inc | Stock-Other | 1.37% | — | -9.36% | |
| 22 | VCEL | Vericel CORP | Stock-Other | 1.36% | -0.32% | EXIT | |
| 23 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.35% | -0.11% | — | |
| 24 | ABBV | Abbvie Inc | Stock-Healthcare | 1.29% | -0.04% | -7.10% | |
| 25 | AKTSQ | Akoustis Technologies Inc | Stock-Other | 1.19% | — | +296.46% | |
| 26 | GIS | General Mills Inc | Stock-Consumer Staples | 1.18% | +0.03% | — | |
| 27 | VFF | Village Farms International | Stock-Other | 1.15% | — | +5.20% | |
| 28 | MGNI | Magnite Inc | Stock-Other | 1.15% | +0.14% | — | |
| 29 | OOMA | Ooma Inc | Stock-Other | 1.11% | +0.21% | +7.74% | |
| 30 | TGT | Target CORP | Stock-Consumer Disc | 1.10% | -0.07% | — | |
| 31 | PERI | Perion Network Ltd. | Stock-Other | 1.09% | -0.21% | -1.69% | |
| 32 | TCMD | Tactile Systems Technology I | Stock-Other | 1.08% | — | -1.11% | |
| 33 | OPRX | Optimizerx CORP | Stock-Other | 1.07% | -0.02% | — | |
| 34 | PFE | Pfizer Inc | Stock-Healthcare | 1.06% | -0.30% | — | |
| 35 | SKYT | Skywater Technology Inc | Stock-Other | 1.00% | -0.35% | -0.42% | |
| 36 | TELA | Tela Bio Inc | Stock-Other | 0.99% | -0.01% | -0.12% | |
| 37 | BLZE | Backblaze Inc-a | Stock-Other | 0.91% | +2.75% | — | |
| 38 | ✓ | Mdxhealth SA | Stock-Other | 0.90% | -2.72% | — | |
| 39 | COP | Conocophillips | Stock-Energy | 0.85% | -0.22% | — | |
| 40 | ✓ | Streamline Health Solutions | Stock-Other | 0.80% | — | -0.13% | |
| 41 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.79% | -0.22% | -0.39% | |
| 42 | INTC | Intel CORP | Stock-Tech | 0.77% | — | -2.55% | |
| 43 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 0.75% | -0.09% | — | |
| 44 | BAX | Baxter International Inc | Stock-Healthcare | 0.73% | — | -0.12% | |
| 45 | ATRC | Atricure Inc | Stock-Other | 0.71% | -0.31% | — | |
| 46 | CIEN | Ciena CORP | Stock-Tech | 0.69% | -0.80% | -2.90% | |
| 47 | AAPL | Apple Inc | Stock-Tech | 0.66% | -0.03% | — | |
| 48 | EMKREUR | Emcore CORP | Stock-Other | 0.66% | — | -1.07% | |
| 49 | XGN | Exagen Inc | Stock-Other | 0.65% | +0.01% | -3.01% | |
| 50 | FAST | Fastenal Co | Stock-Industrials | 0.62% | -0.05% | — |
According to official SEC Form 13F filings, Perkins Capital Management Inc reported a total U.S. public equity portfolio value of $127.2M across 90 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including LLY, MSFT, AUGX) accounted for 26.2% of total reported equity market value during Q1 2024.
During Q1 2024, Perkins Capital Management Inc's top holdings by market value included LLY (8.2%)、MSFT (5.3%)、AUGX (5.0%). The largest single position, LLY, represented 8.2% of total portfolio value.
In Q1 2024, Perkins Capital Management Inc made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.